Related Experiment Video
Updated: Jul 27, 2025

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.0K
Microscopic polyangiitis initially presenting with idiopathic pulmonary fibrosis: a case report
Chi Shao1, Ruxuan Chen1, Hui Huang1
1Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Frontiers in Medicine
|June 9, 2023
Summary
Microscopic polyangiitis (MPA) can mimic idiopathic pulmonary fibrosis (IPF), leading to delayed diagnosis. This case highlights ANCA-associated vasculitis presenting as interstitial lung disease, emphasizing the need for comprehensive evaluation.
Area of Science:
- Rheumatology
- Pulmonology
- Nephrology
Background:
- Microscopic polyangiitis (MPA) frequently involves the lungs, presenting as interstitial lung disease (ILD).
- Usual interstitial pneumonia is a common manifestation of MPA-associated ILD.
- Patients may initially present with pulmonary fibrosis, mimicking idiopathic pulmonary fibrosis (IPF).
Observation:
- A patient presented with fever of unknown origin, microscopic hematuria, and renal insufficiency.
- The patient had been treated for presumed idiopathic pulmonary fibrosis (IPF) with antifibrotic medication for nearly a decade.
- Antineutrophil cytoplasmic antibody (ANCA) testing was positive.
Findings:
- The patient was diagnosed with microscopic polyangiitis (MPA) based on clinical presentation and positive ANCA.
- Delayed diagnosis of MPA occurred due to initial misdiagnosis as IPF.
- Treatment with glucocorticoids and immunosuppressants led to symptom improvement.
Implications:
- This case underscores the importance of considering ANCA-associated vasculitis in patients with unexplained pulmonary fibrosis and systemic symptoms.
- Early and accurate diagnosis of MPA is crucial to prevent irreversible organ damage.
- Comprehensive diagnostic workup, including serological testing, is essential for differentiating MPA-ILD from IPF.

